P. Smalley
Director/Board Member bij Valo Health LLC
Profiel
P.
Adam Smalley is currently a Director at Valo Health, Inc. and a Senior Director-Credit Investments at Psp Investment, Inc. He also holds a Director position at Valo Health LLC.
Smalley completed his undergraduate degree at Bucknell University and earned an MBA from Columbia Business School.
Actieve functies van P. Smalley
Bedrijven | Functie | Begin |
---|---|---|
Valo Health LLC
Valo Health LLC Packaged SoftwareTechnology Services Valo Health LLC operates as a drug discovery technology company. It offers cloud computing as well as longitudinal and human data to create an entirely new drug discovery and development process. The company was founded in 2019 and is headquartered in Boston, MA. | Director/Board Member | - |
Psp Investment, Inc. | Corporate Officer/Principal | 01-05-2016 |
Valo Health, Inc.
Valo Health, Inc. Financial ConglomeratesFinance Part of Valo Health LLC, Valo Health, Inc. operates as a development stage company. The private company is based in Boston, MA. The company was founded by David A. Berry. David A. Berry has been the CEO since incorporation. | Director/Board Member | 01-02-2021 |
Opleiding van P. Smalley
Bucknell University | Undergraduate Degree |
Columbia Business School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Valo Health, Inc.
Valo Health, Inc. Financial ConglomeratesFinance Part of Valo Health LLC, Valo Health, Inc. operates as a development stage company. The private company is based in Boston, MA. The company was founded by David A. Berry. David A. Berry has been the CEO since incorporation. | Finance |
Psp Investment, Inc. | |
Valo Health LLC
Valo Health LLC Packaged SoftwareTechnology Services Valo Health LLC operates as a drug discovery technology company. It offers cloud computing as well as longitudinal and human data to create an entirely new drug discovery and development process. The company was founded in 2019 and is headquartered in Boston, MA. | Technology Services |